Lights

When in danger humans are similar to a deer in the headlights

Standing still when a threat is detected is a defensive, protective reaction. This ancestral and automatic behavior allows the prey to stay unnoticed by a potential predator. A new study published in Psychophysiology finds that humans, like many other complex animals, freeze when encountering a threat. The mere picture of an injured or mutilated human induces this reaction. When viewing these unp...

New book highlights world's borderless conservation areas

Publication emphasizes global focus on protecting Earth's ecosystems across national boundariesNature knows no borders, according to a new book released today by CEMEX, Conservation International, and Agrupacion Sierra Madre. "Transboundary Conservation: A New Vision for Protected Areas," describes in detail new strategies of shared environmental responsibility for keeping important wilde...

Learning to love bacteria: Stanford scientist highlights bugs' benefits

Bacteria are bad. Mothers and doctors, not to mention the cleaning product industry, repeatedly warn of their dangers. But a Stanford University School of Medicine microbiologist is raising the intriguing idea that persistent bacterial and viral infections have benefits. Stanley Falkow, PhD, the Robert W. and Vivian K. Cahill Professor in Cancer Research, is publishing his thoughts on this...

Bird flu study highlights need to vaccinate flocks effectively

Incomplete vaccination of poultry flocks could make the spread of deadly strains of avian flu such as H5N1 worse, scientists at the Universities of Edinburgh and Warwick have found. The research shows that even though the available vaccines are effective on individual birds, the disease is likely to spread unless almost all of a flock has been protected. The study, published in Nature journal, is...

Research highlights how bacteria produce energy

The world's smallest life forms could be the answer to one of today's biggest problems: providing sustainable, renewable energy for the future. Using a variety of natural food sources, bacteria can be used to create electricity, produce alternative fuels like ethanol and even boost the output of existing oil wells, according to research being presented this week at the 106th General Meeting of...

More>>

Lights at Biology Products

LIGHTSHIFT EMSA Kit from Pierce Biotechnology, Inc.

Description:The electrophoretic mobility shift assay (EMSA) is a powerful tool for evaluating DNA-protein interactions. Often referred to as gel shift or gel retardation, the assay is based on the principle that when subjected to electrophoresis, free DNA will migrate differently than a DNA-protein complex. The Pierce LightShift Chemiluminescent EMSA Kit is a nonradioactive system for performing EMSA using P...
Company:Pierce Biotechnology, Inc.

Lights at Biology Technology

Forbes highlights Wisconsin biotech, names Madison #1 business city

MADISON - Madison, Wisconsin was ranked the number-one city in the United States for business and careers by Forbes magazine, followed by Raleigh-Durham and Austin, in the In 2003, the city ranked 5th and was selected this year as th...

Lights, cameras, action: The state of online video

. YouTube, a video sharing site and Web 2.0 phenomena, has well over 34 million unique visitors spending almost 30 minutes monthly on the s...

Broadband blues: Don't fall for Lightspeed hype

In the great race for global competitiveness, economic development equals broadband connectivity and broadband connectivity equals jobs. The fuel for broadband connectivity is the need for speed. Thats all the consumer need...

AT&T should set sights higher than repackaging DSL with Project Lightspeed

If you're going to go through all this redeployment, AT&T should be setting its sights higher on real broadband and long-term capabilities. Providing another flavor of DSL is shortsighted. The marketing strategy of Project Lightspeed should be to...

Orion Energy turns the lights up and energy usage down

Plymouth, WI The new lights which offer 50 percent more light at half the energy usage are designed as a four-lamp fixt...

More>>

Lights at Medicine News

“Don’t fear long haul flights!” Vascular surgeon tells travelrs

Dr. John Scurr, a vascular surgeon at London's Middlesex Hospital, advices passengers, who fly long haul flights, that there is nothing to fear. The death of a woman on board an airliner, while she was flying a long distance flight, has sparked off this sudden debate that long flights can be fatal to many people. Dr. Scurr says this fear is unfounded and that people are just ove...

Nightlights could ward diabetic blindness

According to researchers, illumination during the hours of darkness might prevent retinal damage in diabetes. One of the major complications of diabetes is a form of blindness called diabetic retinopathy. This results from damage to the retina //- the layer of tissue at the back of the eye which responds to light.In diabetes, the blood supply to the eye is impaired and this has an impact on the r...

SARS make Air India cut flights

India's international carrier, Air India, has decided to make more cuts to its flights to Hong Kong because of concerns over Severe Acute Respiratory Syndrome (SARS). The move comes as the body representing India's commercial pilots issued directives to its members not to fly on the Bombay-Hong Kong route. However Air India flights will be operated by pilots who are not members of the pilots body...

Lights can lighten your moods

Many of the mood swings including clinical conditions like seasonal affective disorder (SAD) may be cured by light //therapy, says the scientists of University of North Carolina. Researchers had studied adults of age 18 to 65 yrs who had met the mood disorder diagnosis. Treatment was based on dawn stimulation for SAD, bright light treatment for non-seasonal depressions and convention...

Bright arctic lights to cause headaches

People suffering from migraines and living in the arctic area may have more attacks of headaches triggered// by the bright arctic lights. Researchers of Norway, who had presented the findings at the American Academy of Neurology 57th Annual Meeting at Miami, said that people reported increased incidence of headaches which have been traced to the increased light and not to any biologica...

More>>

Lights at Medicine Products

Halogen Lightsources

Description:Halogen technology provides a high light intensity. Light intensity is variable by 5 different brightness steps (Halogen 150) respectively continuously (Halogen 250). Light output can be adapted to different illumination conditions (large cavity, small diameter scope, etc.). Different lightcable adapters available....
Company:B. Braun Medical Inc.

MC-3 Lightsource

Description:The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Company:Codman

Twin-Beam Lightsource

Description:The Twin Beam lightsource is a standard light source. The Twin Beam contains two 150W, DNF lamps, one primary lamp, the other to serve as a built-in spare lamp. This allows rapid change to the spare in the event the primary lamp burns out....
Company:Codman

Coaxial Fiberoptic Headlights

Description:Coaxial fiberoptic headlight has fixed spot size of 120mm. It weighs only 4.5 ounces....
Company:Techman International Corporation

LightSpeed VCT 64-slice Scanner

Description:Volume coverage, not slices, changes the way anatomy is imaged and how studies are performed. The LightSpeed VCT Series of scanners combine superior resolution with outstanding coverage making the imaging of difficult patients or procedures more routine. The LightSpeed VCT Series groundbreaking technology opens the door to new procedures while improving the imaging of existing ones. Impro...
Company:GE Healthcare

More>>

Lights at Medicine Technology

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 10, 2007 - BusinessWeekpublished an article on July 6 discussing the race bypharmaceutical and biotechnology companies to be first to bring tomarket an effective angiogenesis treatment for cardiovasculardisease. While angiogenesis therapies are being pursued bySanofi-Aventis, Boston Scientific, Baxter, and Genzyme, amongothers, the article highlights a...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek todaypublished an article discussing the race by pharmaceutical andbiotechnology companies to be first to bring to market an effectiveangiogenesis treatment for cardiovascular disease. Whileangiogenesis therapies are being pursued by Sanofi-Aventis, BostonScientific, Baxter, and Genzyme, among others, the articlehighlights a very...

Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal

Focus On AV411's Unique Mechanism of Action and Broad Potential forthe Treatment of Neurological Conditions ALAMEDA, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc.(Nasdaq:AVGN), a biopharmaceutical company innovating therapeuticsfor the treatment of neurological conditions, announced today thatExpert Opinion on Investigational Drugs has published an articlefeaturing...

Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event

Recent clinical studies support the development of DG041 as aneffective anti-platelet that does not increase bleeding risk REYKJAVIK, Iceland, June 25, 2007 /PRNewswire-FirstCall/ --deCODE genetics today announced progress in the development ofDG041, the company's Phase II developmental compound for theprevention of arterial thrombosis. The results of the Phase IIa andclinical pharmacolog...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

MONTREAL, QUEBEC--(CCNMatthews - June 14, 2007) - AmbriliaBiopharma Inc. (TSX:AMB), a biopharmaceutical company developingnovel small molecules and peptides to treat infectious diseases andcancer, held its Annual General and Special Meeting today, duringwhich the data reported yesterday on its novel series of HIVintegrase inhibitors and recent developments were highlighted. Themeeting wa...

More>>